BioTelemetry Technology ApS
Nøgletal
- Afkastningsgrad
- –
- Egenkapitalforrentning
- -0,6 %
- Likviditetsgrad
- 5.429,2 %
- Soliditetsgrad
- 98,2 %
Resultat
| Regnskabsperiode | |
|---|---|
Bruttoresultat | -115.998 |
Skat af årets resultat | -26.022 |
Årets resultat | -92.258 |
Medarbejdere
| Regnskabsperiode | |
|---|---|
Gns. ansatte | 0 |
Balance
| Regnskabsperiode | |
|---|---|
Likvider | 235.952 |
Kortfristede aktiver | 15.373.622 |
Aktiver i alt | 15.373.622 |
Egenkapital | 15.090.457 |
Forpligtelser i alt | 283.165 |
Kortfristede forpligtelser | 283.165 |
Arbejdskapital
| Regnskabsperiode | |
|---|---|
Andre kortfristede tilgodehavender | 27.072 |
Leverandørgæld | 283.165 |
Kapital og udbytte
| Regnskabsperiode | |
|---|---|
Selskabskapital | 50.000 |
Overført resultat | 40.457 |
Foreslået udbytte | 15.000.000 |
Højdepunkter fra årsrapporten
Forretning og udvikling
The Entity's primary activity is distribution of medical instruments and equipment.
The Entity is intented to be liquidated in 2023.
Profit/loss for the year in relation to expected developmentsThe loss for the year is DKK 92 thousand. The loss is in line with the expectations.
Risici og væsentlige forhold
No events have occurred after the balance sheet date to this date, which would influence the evaluation of this annual report.
Forpligtelser og sikkerhedsstillelser
The Entity participates in a Danish joint taxation arrangement where Philips Danmark A/S serves as the administration company. According to the joint taxation provisions of the Danish Corporation Tax Act, the Entity is therefore liable for income taxes etc for the jointly taxed entities, and for obligations, if any, relating to the withholding of tax on interest, royalties and dividend for the jointly taxed entities. The jointly taxed entities' total known net liability under the joint taxation arrangement is disclosed in the administration company's financial statements.
Se op til 9 års regnskabshistorik ved at oprette en gratis bruger
Opret gratis bruger